- Trials with a EudraCT protocol (194)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (1)
194 result(s) found for: Digestive Tract.
Displaying page 1 of 10.
EudraCT Number: 2007-001928-12 | Sponsor Protocol Number: 17/2007/U/Sper | Start Date*: 2007-04-23 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI | |||||||||||||
Full Title: Contrast enhanced ultrasonography effectiveness in early evaluating of the response to the Sunitinib in the patients with advanced GIST. A pilot study | |||||||||||||
Medical condition: Gastrointestinal stromal tumor (GIST) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-003048-11 | Sponsor Protocol Number: GIPIT002 | Start Date*: 2014-10-24 |
Sponsor Name:GIPIT | ||
Full Title: FEcal transplant, a Dazzling debut to Eradicate colonization with eXtreme drug resistant bacteria? | ||
Medical condition: Patient harboring Extreme Drug Resistant (XDR) bacteria. Our trial try to eradicate this digestive tract colonization by performing a fecal transplantation. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2009-015070-35 | Sponsor Protocol Number: RB 09.091 | Start Date*: 2010-05-18 | |||||||||||
Sponsor Name:CHRU de BREST | |||||||||||||
Full Title: Evaluation de l'intérêt d'une préparation de l'intestin Grèle par polyéthylèneglycol pour l'exploration par vidéocapsule endoscopique des saignements digestifs inexpliqués | |||||||||||||
Medical condition: Saignement digestif inexpliqué extériorisé ou non associé à une anémie | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-004624-41 | Sponsor Protocol Number: 24092020 | Start Date*: 2021-07-07 | ||||||||||||||||
Sponsor Name:Zealand University Hospital | ||||||||||||||||||
Full Title: Calcium Electroporation for Malignant GI Bleeding – a randomized controlled trial | ||||||||||||||||||
Medical condition: Malignant gastrointestinal bleeding | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-017819-16 | Sponsor Protocol Number: OP-GIB | Start Date*: 2011-08-22 | ||||||||||||||||
Sponsor Name:Juan Cordoba | ||||||||||||||||||
Full Title: Efectos de la administración de ornitina-fenilacetato (OCR-002) en pacientes con cirrosis y hemorragia digestiva alta. Effects of the administration of ornithine phenylacetate (OP, OCR-002) in pati... | ||||||||||||||||||
Medical condition: Hemorragia digestiva en pacientes con cirrosis hepática | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2007-000065-38 | Sponsor Protocol Number: ASL607LIOM01 COMET-GI | Start Date*: 2007-02-28 | |||||||||||
Sponsor Name:AZIENDA USL 6 LIVORNO ZONA LIVORNESE | |||||||||||||
Full Title: METRONOMIC CHEMOTHERAPY WITH URACIL/TEGAFUR (UFT), CYCLOPHOSPHAMIDE (CTX) AND CELECOXIB IN PRETREATED PATIENTS WITH ADVANCED GASTROINTESTINAL MALIGNANCIES: A PILOT CLINICAL STUDY WITH PHARMACOKINET... | |||||||||||||
Medical condition: PATIENTS WITH ADVANCED GASTROINTESTINAL MALIGNANCIES | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-003192-19 | Sponsor Protocol Number: ISRCTN11225767 | Start Date*: 2013-02-22 | |||||||||||
Sponsor Name:London School Of Hygiene and Tropical Medicine | |||||||||||||
Full Title: Tranexamic acid for the treatment of gastrointestinal haemorrhage: an international randomised, double blind placebo controlled trial | |||||||||||||
Medical condition: Gastrointestinal hemorrhage | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) RO (Completed) ES (Prematurely Ended) IE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-006102-19 | Sponsor Protocol Number: OM1 | Start Date*: 2008-02-25 | ||||||||||||||||
Sponsor Name:Hospital General Universitario Gregorio Marañón de Madrid | ||||||||||||||||||
Full Title: Tratamiento con omeprazol para la profilaxis de la hemorragia digestiva y el reflujo gastroesofágico en niños críticos Omeprazol treatment for prophylaxis of gastrointestinal bleeding and gastroes... | ||||||||||||||||||
Medical condition: Profilaxis de hemorragia digestiva y prevención del reflujo gastroesofágico en niños críticos | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-002349-38 | Sponsor Protocol Number: 2-54-52030-156 | Start Date*: 2007-02-26 |
Sponsor Name:Beaufour Ipsen Pharma-Ipsen Biotech Department | ||
Full Title: Phase III multicentre, Randomised, Double Blind, Comparative study to assess the efficacy and safety of lanreotide 30mg versus placebo as a palliative treatment of clinical symptoms associated with... | ||
Medical condition: Patient having a high digestive obstruction of malignant origin i.e. located on the upper part of the gastro-intestinal tract (stomach, duodenum, small bowel) for whom surgery is inappropriate. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-003466-25 | Sponsor Protocol Number: 13.024 | Start Date*: 2014-12-18 | |||||||||||
Sponsor Name:Anders Gadegaard Jensen,Anesthesia and Intensive Care Unit, Odense University Hospital | |||||||||||||
Full Title: Randomized, double-blind, prospective, placebo-controlled trial of the effect of intravenous lidocaine infusion for postoperative pain management and bowel function in robot assisted laparoscopic c... | |||||||||||||
Medical condition: Postoperative pain after colon rectal cancer surgery are mainly intended to relieve as well resting as activity-induced pain. Secondarily, the choice of pain management should take into considerati... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-005528-13 | Sponsor Protocol Number: 30112012 | Start Date*: 2014-06-17 | |||||||||||
Sponsor Name:Helsinki University Hospital | |||||||||||||
Full Title: Comparison of Novel Articaine Lozenge Versus Placebo for Upper Gastrointestinal Endoscopy in Adults. A Randomized Double-blinded Controlled Study | |||||||||||||
Medical condition: Patients who undergo esophagogastroduodenoscopy procedure for a first time | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-004981-14 | Sponsor Protocol Number: OOI/KEMB/2006-2 | Start Date*: 2006-12-20 |
Sponsor Name:National Institute of Oncology, Budapest, Hungary | ||
Full Title: Phase II., non randomized, open study: inoperable gall bladder or biliary tract EGFR expressing carcinoma treatment with Erbitux and 5-fluorouracil, epiadriamycin, mitomycin containing combination ... | ||
Medical condition: Irresectable biliary tract cancer where palliation is the aim. It could be locally extanded and also metastatic cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-004163-12 | Sponsor Protocol Number: RP2017-001 | Start Date*: 2018-01-28 | |||||||||||
Sponsor Name:ReposPharma | |||||||||||||
Full Title: A phase 2a TDM-guided clinical study on the safety and efficacy of mebendazole in patients with advanced gastrointestinal cancer or cancer of unknown origin | |||||||||||||
Medical condition: Squamous cell cancer or adenocarcinoma, including primary cancer of the liver, of the gastrointestinal tract or cancer of unknown origin | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-005144-84 | Sponsor Protocol Number: ML20383 | Start Date*: 2007-02-14 | |||||||||||
Sponsor Name:Roche SAS | |||||||||||||
Full Title: Essai de phase II évaluant l’efficacité et la tolérance de bevacizumab associé à une chimiothérapie dans le traitement de patients atteints de tumeurs endocrines digestives bien différenciées, prog... | |||||||||||||
Medical condition: Tumeurs endocrines digestives et duodéno-pancréatiques | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-003670-14 | Sponsor Protocol Number: NA | Start Date*: 2018-01-11 |
Sponsor Name:University Hospital Limerick | ||
Full Title: The role of selective decontamination of the digestive tract in preventing surgical site infections in elective colorectal resections: a randomized controlled trial (SELDDEC Trial) | ||
Medical condition: Surgical Site Infection | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2009-016716-20 | Sponsor Protocol Number: 08/152/WRI | Start Date*: 2010-03-03 | |||||||||||||||||||||
Sponsor Name:Brighton and Sussex University Hospitals NHS Trust | |||||||||||||||||||||||
Full Title: Better targeting of antidepressants in older people: the influence of age and genetic background on serotonin signalling | |||||||||||||||||||||||
Medical condition: Depression | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-002192-18 | Sponsor Protocol Number: PrucaloprideRNAseq | Start Date*: 2018-09-14 |
Sponsor Name:KU Leuven | ||
Full Title: Characterization of nerve-modulated macrophage population in the gastrointestinal tract | ||
Medical condition: Patients undergoing colorectal surgery due to benign or malignant carcinoma, diverticulitis or constipation drug will be used to differentiate between macrophages that are modulated by enteric neu... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-004579-29 | Sponsor Protocol Number: DDD17ATZ | Start Date*: 2018-02-08 |
Sponsor Name:KU Leuven Drug Delivery & Disposition | ||
Full Title: Gastrointestinal behavior of atazanavir in healthy volunteers | ||
Medical condition: Healthy human volunteers | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-002944-26 | Sponsor Protocol Number: DDD19DASA | Start Date*: 2020-01-24 |
Sponsor Name:KU Leuven Drug Delivery & Disposition | ||
Full Title: Exploring the gastrointestinal behavior of dasatinib in healthy volunteers | ||
Medical condition: Healthy human male volunteers | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: BE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2019-000460-21 | Sponsor Protocol Number: DDD19DAS | Start Date*: 2019-04-23 |
Sponsor Name:KU Leuven Drug Delivery & Disposition | ||
Full Title: Gastrointestinal behavior of dasatinib in healthy volunteers | ||
Medical condition: Healthy human volunteers | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Prematurely Ended) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.